OPPOSITE EFFECTS OF TRANSFORMING GROWTH-FACTOR-ALPHA AND EPIDERMAL GROWTH-FACTOR ON MOUSE PLACENTAL-LACTOGEN-I SECRETION

This study was undertaken to determine whether transforming growth fac tor alpha (TGF-alpha) regulates the production of mouse placental lact ogen I (mPL-I) and mPL-II in a manner that is similar to that of epide rmal growth factor (EGF), which was previously shown to stimulate mPL- I secretion and inhibit mPL-II, secretion. In contrast to the activity of EGF, human (h) and rat (r) TGF-alpha (each at 100 ng/ml) inhibited secretion of mPL-I by placental cells isolated from mice on day 7 of pregnancy. Maximum inhibition of mPL-I secretion occurred on the third day of a 5-day culture period and ranged between 37% and 56% in multi ple trials. Incubation of cells with hTGF-alpha and EGF was not follow ed by a change in the mPL-I concentration of the medium, suggesting th e peptides antagonized each other's effects. hTGF-alpha and rTGF-alpha inhibited secretion of mPL-II; maximum inhibition ranged between 62% and 84% in multiple trials. The lowest concentrations of hTGF-alpha th at affected mPL-I and mPL-II secretion were 10 ng/ml and 1 ng/ml, resp ectively. EGF and hTGF-alpha bound to the same receptors on placental cells, as assessed by cross-linking, and both peptides stimulated rece ptor phosphorylation, as assessed by Western blot analysis. There are three types of mPL-containing cells in placental cultures: cells that contain only mPL-I, cells that contain only mPL-II, and cells that con tain both mPLs. The percentage of each type of mPL-containing cell in the culture was determined by immunostaining. hTGF-alpha affected the differentiation of the subpopulations of PL-containing cells in a mann er that differed from that of EGF. The data suggest that TGF-alpha and EGF do not regulate the production of mPL-I and mPL-II in a similar m anner.